Winner of the 2018 Silver Alexander Hamilton Award in Financial Risk Management: Alexion Pharmaceuticals.

With five weeks to go before tariffs on Chinese goods more than double, Wilbur Ross says a trade deal remains distant, although there's a “fair chance” we'll get there eventually.

U.S. Commerce Secretary tells unpaid federal workers: “There really is not a good excuse why there really should be a liquidity crisis.”

Does a reduction in expected frequency of interest rate increases for 2019 mean we're nearing the highest rates of this business cycle?

From downed cell phone towers to water shortages, some of the U.S.'s largest companies consider the damage—and opportunities—that long-term global warming could present for their businesses.

Offer might technically eliminate the trade deficit, but it wouldn't address underlying issues such as intellectual property or China's government support of industry.

Businesses with U.S. ties have seen share prices drop after visits from the Dublin tax inspector. Some executives are reconsidering Irish expansion plans, while others move forward undeterred.

6 steps to developing a framework for folding acquisitions into the corporate treasury function.